Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: Am J Nephrol. 2019 Jan 24;49(2):133–142. doi: 10.1159/000496484

Figure 3:

Figure 3:

Odds ratios of various stages of AKI (vs. no AKI) associated with vancomycin vs. non-glycopeptide use, in propensity score-matched patients overall and in groups categorized by maximum trough serum vancomycin level.